The promise of exosome applications in treating central nervous system diseases.

CNS Neuroscience & Therapeutics
Jared MattinglyJinju Wang

Abstract

Exosomes (EXs), a type of extracellular vesicles, are secreted from virtually all types of cells. EXs serve as cell-to-cell communicators by conveying proteins and nucleic acids with regulatory functions. Increasing evidence shows that EXs are implicated in the pathogenesis of central nervous system (CNS) diseases. Moreover, EXs have recently been highlighted as a new promising therapeutic strategy for in vivo delivery of nucleotides and drugs. Studies have revealed that infusion of EXs elicits beneficial effects on the CNS injury animal models. As compared to cell-based therapy, EXs-based therapy for CNS diseases has unique advantages, opening a new path for neurological medicine. In this review, we summarized the current state of knowledge of EXs, the roles and applications of EXs as a viable pathological biomarker, and EX-based therapy for CNS diseases.

References

Aug 3, 2002·Nature Reviews. Immunology·Clotilde ThérySebastian Amigorena
Feb 1, 2006·Molecular and Cellular Neurosciences·J FauréR Sadoul
Jul 14, 2006·Proceedings of the National Academy of Sciences of the United States of America·Lawrence RajendranKai Simons
Dec 19, 2007·Circulation·Wayne RosamondUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Mar 1, 2008·Science·Katarina TrajkovicMikael Simons
Jul 1, 2009·The Journal of Cell Biology·Russell E McConnellMatthew J Tyska
Jun 24, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Dongmei SunHuang-Ge Zhang
Apr 7, 2011·Methods in Molecular Biology·Douglas D TaylorCicek Gercel-Taylor
Feb 4, 2012·The Journal of Biological Chemistry·Kohei YuyamaYasuyuki Igarashi
Jun 14, 2013·Biological Research·María A Lopez-Verrilli, Felipe A Court
Sep 4, 2013·Current Opinion in Neurobiology·Pranav SharmaHollis T Cline
Nov 12, 2013·Neurology·Carlo Sala FrigerioBart De Strooper
Oct 8, 2014·Annual Review of Cell and Developmental Biology·Marina ColomboClotilde Théry
Oct 16, 2014·Journal of Extracellular Vesicles·Jan Van DeunAn Hendrix
Dec 3, 2014·Journal of Chromatography. a·Mitja L HeinemannJody Vykoukal
Apr 4, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Matthew J HaneyElena V Batrakova
Dec 15, 2015·Neuropathology and Applied Neurobiology·Kelly Del Tredici, Heiko Braak
Jan 27, 2016·Biomolecular Concepts·Kohei Yuyama, Yasuyuki Igarashi
Feb 10, 2016·Proceedings of the National Academy of Sciences of the United States of America·Joanna KowalClotilde Théry
Feb 28, 2016·Lancet·Philip ScheltensWiesje Maria Van der Flier
May 2, 2016·Neurochemistry International·Tarja MalmKatja M Kanninen
May 28, 2016·Nature Reviews. Endocrinology·Adeel SafdarMark A Tarnopolsky
Oct 26, 2016·Cellular Microbiology·Eloise J O'Donoghue, Anne Marie Krachler
Nov 3, 2016·Journal of Extracellular Vesicles·Chris GardinerAndrew F Hill
Feb 25, 2017·Stroke; a Journal of Cerebral Circulation·Hongqi XinMichael Chopp

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.